A detailed history of Agf Investments Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Agf Investments Inc. holds 572,858 shares of BMY stock, worth $33 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
572,858
Previous 591,728 3.19%
Holding current value
$33 Million
Previous $45.6 Million 10.62%
% of portfolio
0.39%
Previous 0.41%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $2,453 - $1.45 Million
-18,870 Reduced 3.19%
572,858 $40.7 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $1.44 Million - $1.58 Million
-19,798 Reduced 3.24%
591,728 $45.6 Million
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $4.53 Million - $5.43 Million
-73,719 Reduced 10.76%
611,526 $44.7 Million
Q4 2021

Feb 01, 2022

SELL
$53.63 - $62.52 $1.6 Million - $1.86 Million
-29,829 Reduced 4.17%
685,245 $42.7 Million
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $14 Million - $16.3 Million
-235,881 Reduced 24.8%
715,074 $42.3 Million
Q2 2021

Aug 10, 2021

SELL
$61.91 - $67.42 $2.81 Million - $3.06 Million
-45,426 Reduced 4.56%
950,955 $63.5 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $5.14 Million - $5.78 Million
-86,599 Reduced 8.0%
996,381 $62.9 Million
Q4 2020

Feb 08, 2021

SELL
$57.74 - $65.43 $6.35 Million - $7.19 Million
-109,957 Reduced 9.22%
1,082,980 $67.2 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $22,569 - $25,010
393 Added 0.03%
1,192,937 $71.9 Million
Q2 2020

Aug 11, 2020

SELL
$54.82 - $64.09 $1.54 Million - $1.8 Million
-28,051 Reduced 2.3%
1,192,544 $70.1 Million
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $1.63 Million - $2.37 Million
35,115 Added 2.96%
1,220,595 $68 Million
Q4 2019

Feb 12, 2020

SELL
$49.21 - $64.19 $1.47 Million - $1.91 Million
-29,804 Reduced 2.45%
1,185,480 $76.1 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $1.28 Million - $1.52 Million
-30,015 Reduced 2.41%
1,215,284 $61.6 Million
Q2 2019

Jul 30, 2019

SELL
$44.62 - $49.34 $1.84 Million - $2.04 Million
-41,286 Reduced 3.21%
1,245,299 $56.5 Million
Q1 2019

May 10, 2019

SELL
$45.12 - $53.8 $544,327 - $649,043
-12,064 Reduced 0.93%
1,286,585 $61.4 Million
Q4 2018

Feb 08, 2019

BUY
$48.76 - $63.23 $351,267 - $455,508
7,204 Added 0.56%
1,298,649 $67.5 Million
Q3 2018

Nov 07, 2018

SELL
$55.19 - $62.25 $392,566 - $442,784
-7,113 Reduced 0.55%
1,291,445 $80.2 Million
Q2 2018

Aug 10, 2018

BUY
$50.53 - $62.98 $6 Million - $7.48 Million
118,814 Added 10.07%
1,298,558 $71.9 Million
Q1 2018

May 04, 2018

BUY
$59.92 - $68.98 $1.23 Million - $1.41 Million
20,487 Added 1.77%
1,179,744 $74.6 Million
Q4 2017

Feb 07, 2018

SELL
$59.94 - $65.35 $1.14 Million - $1.24 Million
-18,968 Reduced 1.61%
1,159,257 $71 Million
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $65.1 Million - $75.1 Million
1,178,225
1,178,225 $75.1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Agf Investments Inc. Portfolio

Follow Agf Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments Inc. with notifications on news.